Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Terminated × Non-Small Cell Lunch Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 252 Carcinoma, Non-Small-Cell Lung 222 Leukemia, Myeloid, Acute 172 Breast Neoplasms 140 Melanoma 135 Neoplasm Metastasis 125 Multiple Myeloma 111 Colorectal Neoplasms 104 Recurrence 101 Lymphoma 100 Lymphoma, Non-Hodgkin 97 Leukemia, Lymphocytic, Chronic, B-Cell 94 Ovarian Neoplasms 91 Pancreatic Neoplasms 88 Precursor Cell Lymphoblastic Leukemia-Lymphoma 81 Leukemia 78 Prostatic Neoplasms 75 Lung Neoplasms 71 Squamous Cell Carcinoma of Head and Neck 66 Glioblastoma 66 Carcinoma, Renal Cell 66 Lymphoma, Large B-Cell, Diffuse 65 Myelodysplastic Syndromes 59 Lymphoma, Follicular 57 Brain Neoplasms 54 Sarcoma 48 Lymphoma, Mantle-Cell 47 Stomach Neoplasms 45 Head and Neck Neoplasms 45 Glioma 41

Interventions

Paclitaxel 1 NVP-BKM120 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01820325 2018-10-11

BASALT-2

Novartis

Phase 1 Terminated

Non-Small Cell Lunch Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡